Oryzon Gets Spanish Approval for Iadademstat Combination Study in Newly Diagnosed AML
Spanish approval allows Oryzon to evaluate an iadademstat combination in newly diagnosed AML patients.
Related stories
Kia America October Sales Rise 16%
Kia America said it achieved record overall and retail sales for a sixth consecutive month, driven by demand for electrified vehicles and hybrids. It sold 80,008 vehicles.
M impact | EQUITY | Nov 03, 2026, 10:54 AM UTC
Advanced Info Service Reports Quarterly Revenue of 58.06 Billion Baht
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
Cosmo First Q2 Consolidated Revenue From Operations INR 13,878.6 Million
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
Cosmo First Reports Q2 Consolidated Net Profit of INR 985.8 Million
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
Advanced Info Service Reports Quarterly Profit of 13.50 Billion Baht
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC
TSX Futures Slip as Oil Rebounds; US Midterms in Focus
Canadian stock futures slipped as oil rebounded, with US midterm elections in focus.
M impact | EQUITY | Nov 03, 2026, 10:53 AM UTC